Barriers to anti-fungal prophylaxis: Almost Done!
At your center, what are the barriers you and your colleagues experience to prescribing anti-fungal prophylaxis for lung transplant candidates or recipients (Select up to 3 answers)?
□ Cost of the medications
□ Drug interactions
□ Insurance prior authorizations
□ Insurance denial of coverage
□ Lack of formalized guidelines for anti-fungal prophylaxis
□ Lack of strong quality evidence for the use of anti-fungal prophylaxis
□ Lack of intravenous access
□ Pill burden
□ Side effects of anti-fungal agents
□ Other
Please describe “Other”
From a patient perspective, what do you believe are the barriers to adherence of anti-fungal prophylaxis (Select up to 3 answers)?
□ Cost of the medications
□ Drug interactions
□ Insurance prior authorizations
□ Insurance denial of coverage
□ Lack of foreseen benefit
□ Pill burden
□ Risk of malignancy
□ Side effects of anti-fungal agents
□ Other
Please describe “Other”